Crosstalk Between Adrenergic and Toll‐Like Receptors in Human Mesenchymal Stem Cells and Keratinocytes: A Recipe for Impaired Wound Healing

Previous studies demonstrate that skin wounds generate epinephrine (EPI) that can activate local adrenergic receptors (ARs), impairing healing. Bacterially derived activators of Toll‐like receptors (TLRs) within the wound initiate inflammatory responses and can also impair healing. In this study, we examined the hypothesis that these two pathways crosstalk to one another, using EPI and macrophage‐activating lipopeptide‐2 (MALP2) to activate ARs and TLR2, respectively, in human bone marrow‐derived mesenchymal stem cells (BM‐MSCs) and neonatal keratinocytes (NHKs). BM‐MSCs exposed to EPI significantly (p < .05) increased TLR2 message (sevenfold BM‐MSCs), TLR2 protein (twofold), and myeloid differentiation factor 88 (MyD88) (fourfold). Conversely, activation of TLR2 by MALP2 in these cells increased β2‐AR message (twofold in BM‐MSCs, 2.7‐fold in NHKs), β2‐AR protein (2.5‐fold), phosphorylation of β‐AR‐activated kinase (p‐BARK, twofold), and induced release of EPI from both cell types (twofold). Treating cells with EPI and MALP2 together, as would be encountered in a wound, increased β2‐AR and p‐BARK protein expression (sixfold), impaired cell migration (BM‐MSCs‐ 21%↓ and NHKs‐ 60%↓, p < .002), and resulted in a 10‐fold (BM‐MSCs) and 51‐fold (NHKs) increase in release of IL‐6 (p < .001) responses that were remarkably reduced by pretreatment with β2‐AR antagonists. In vivo, EPI‐stressed animals exhibited impaired healing, with elevated levels of TLR2, MyD88, and IL‐6 in the wounds (p < .05) relative to nonstressed controls. Thus, our data describe a recipe for decreasing cell migration and exacerbating inflammation via novel crosstalk between the adrenergic and Toll‐like receptor pathways in BM‐MSCs and NHKs.

[1]  Xueer Wang,et al.  Activin B Promotes BMSC-Mediated Cutaneous Wound Healing by Regulating Cell Migration via the JNK-ERK Signaling Pathway. , 2014, Cell transplantation.

[2]  Min Zhang,et al.  Activin B promotes BMSC-mediated cutaneous wound healing by regulating cell migration via the JNK-ERK signaling pathway. , 2014, Cell transplantation.

[3]  R. Isseroff,et al.  Catecholamine stress alters neutrophil trafficking and impairs wound healing by β2 adrenergic receptor mediated upregulation of IL-6 , 2013, The Journal of investigative dermatology.

[4]  R. Isseroff,et al.  Successful treatment of a chronic venous leg ulcer using a topical beta-blocker. , 2013, Journal of the American Academy of Dermatology.

[5]  P. Peplow,et al.  A review of the influence of growth factors and cytokines in in vitro human keratinocyte migration. , 2013, Cytokine.

[6]  Ç. Tükel,et al.  Epithelial Cells Augment Barrier Function via Activation of the Toll-Like Receptor 2/Phosphatidylinositol 3-Kinase Pathway upon Recognition of Salmonella enterica Serovar Typhimurium Curli Fibrils in the Gut , 2012, Infection and Immunity.

[7]  T. Kadowaki,et al.  Adiponectin Regulates Cutaneous Wound Healing by Promoting Keratinocyte Proliferation and Migration via the ERK Signaling Pathway , 2012, The Journal of Immunology.

[8]  L. Maeng,et al.  Phorbol myristate acetate differentiates human adipose-derived mesenchymal stem cells into functional cardiogenic cells. , 2012, Biochemical and biophysical research communications.

[9]  R. Isseroff,et al.  Toll-like receptors in wound healing: location, accessibility, and timing. , 2012, The Journal of investigative dermatology.

[10]  J. Carvalheira,et al.  Topical Insulin Accelerates Wound Healing in Diabetes by Enhancing the AKT and ERK Pathways: A Double-Blind Placebo-Controlled Clinical Trial , 2012, PloS one.

[11]  Su-Ji Min,et al.  Major stress hormones suppress the response of macrophages through down-regulation of TLR2 and TLR4. , 2012, The Journal of surgical research.

[12]  R. Isseroff,et al.  Toll-like receptors and diabetes: a therapeutic perspective. , 2012, Clinical science.

[13]  R. Kirsner,et al.  Topical Timolol for a Refractory Wound , 2012, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[14]  R. Tuan,et al.  Concise Review: Clinical Translation of Wound Healing Therapies Based on Mesenchymal Stem Cells , 2012, Stem cells translational medicine.

[15]  V. Wheelock,et al.  Genetically Engineered Mesenchymal Stem Cells as a Proposed Therapeutic for Huntington’s Disease , 2011, Molecular Neurobiology.

[16]  M. J. Chalmers,et al.  Ligand-dependent perturbation of the conformational ensemble for the GPCR β2 adrenergic receptor revealed by HDX. , 2011, Structure.

[17]  E. Badiavas,et al.  Potential benefits of allogeneic bone marrow mesenchymal stem cells for wound healing , 2011, Expert opinion on biological therapy.

[18]  E. Sauter,et al.  α1-Adrenergic Receptors Positively Regulate Toll-Like Receptor Cytokine Production from Human Monocytes and Macrophages , 2011, Journal of Pharmacology and Experimental Therapeutics.

[19]  R. Isseroff,et al.  Adrenergic Signaling in Human Oral Keratinocytes and Wound Repair , 2011, Journal of dental research.

[20]  M. Toungouz,et al.  The source of human mesenchymal stromal cells influences their TLR profile as well as their functional properties. , 2011, Cellular immunology.

[21]  D. Federman,et al.  Clinical approach to atypical wounds with a new model for understanding hypertensive ulcers. , 2010, Archives of dermatology.

[22]  I. Jialal,et al.  TLR2 expression and signaling-dependent inflammation impair wound healing in diabetic mice , 2010, Laboratory Investigation.

[23]  G. Cai,et al.  Beta-adrenergic signals regulate adipogenesis of mouse mesenchymal stem cells via cAMP/PKA pathway , 2010, Molecular and Cellular Endocrinology.

[24]  R. Fischmeister,et al.  A new regulation of IL-6 production in adult cardiomyocytes by beta-adrenergic and IL-1 beta receptors and induction of cellular hypertrophy by IL-6 trans-signalling. , 2010, Cellular signalling.

[25]  E. Sauter,et al.  Pro-inflammatory responses in human monocytes are beta1-adrenergic receptor subtype dependent. , 2010, Molecular immunology.

[26]  T. K. Hunt,et al.  Human skin wounds: A major and snowballing threat to public health and the economy , 2009, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[27]  Ming Xu,et al.  Fenoterol, a β2-adrenoceptor agonist, inhibits LPS-induced membrane-bound CD14, TLR4/CD14 complex, and inflammatory cytokines production through β-arrestin-2 in THP-1 cell line , 2009, Acta Pharmacologica Sinica.

[28]  T. Cheng,et al.  DNA synthesis of rat bone marrow mesenchymal stem cells through alpha1-adrenergic receptors. , 2009, Archives of biochemistry and biophysics.

[29]  R. Romieu-Mourez,et al.  Cytokine Modulation of TLR Expression and Activation in Mesenchymal Stromal Cells Leads to a Proinflammatory Phenotype1 , 2009, The Journal of Immunology.

[30]  D. Chinkes,et al.  Acute propranolol infusion stimulates protein synthesis in rabbit skin wound. , 2009, Surgery.

[31]  Yukio Yoneda,et al.  Functional expression of β2 adrenergic receptors responsible for protection against oxidative stress through promotion of glutathione synthesis after Nrf2 upregulation in undifferentiated mesenchymal C3H10T1/2 stem cells , 2009, Journal of cellular physiology.

[32]  Smitha Yerrum,et al.  beta2 Adrenoreceptor blockade attenuates the hyperinflammatory response induced by traumatic injury. , 2009, Surgery.

[33]  David M. Rocke,et al.  Stress-Mediated Increases in Systemic and Local Epinephrine Impair Skin Wound Healing: Potential New Indication for Beta Blockers , 2009, PLoS medicine.

[34]  D. Jezova,et al.  Low- versus High-Baseline Epinephrine Output Shapes Opposite Innate Cytokine Profiles: Presence of Lewis- and Fischer-Like Neurohormonal Immune Phenotypes in Humans? , 2008, The Journal of Immunology.

[35]  J. V. Sarma,et al.  Catecholamines—Crafty Weapons in the Inflammatory Arsenal of Immune/Inflammatory Cells or Opening Pandora’s Box? , 2008, Molecular medicine.

[36]  Yi-Sook Jung,et al.  Norepinephrine- and Epinephrine-induced Distinct β2-Adrenoceptor Signaling Is Dictated by GRK2 Phosphorylation in Cardiomyocytes* , 2008, Journal of Biological Chemistry.

[37]  Ruth S. Waterman,et al.  Toll‐Like Receptors on Human Mesenchymal Stem Cells Drive Their Migration and Immunomodulating Responses , 2008, Stem cells.

[38]  W. Eaglstein,et al.  Microscopic and physiologic evidence for biofilm‐associated wound colonization in vivo , 2008, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[39]  D. Herndon,et al.  Beta-blockade in burns. , 2007, Novartis Foundation symposium.

[40]  R. Neubig,et al.  Phagocyte-derived catecholamines enhance acute inflammatory injury , 2007, Nature.

[41]  Paul G Scott,et al.  Mesenchymal Stem Cells Enhance Wound Healing Through Differentiation and Angiogenesis , 2007, Stem cells.

[42]  D. Greenhalgh,et al.  Cutaneous Wound Healing , 2007, Journal of burn care & research : official publication of the American Burn Association.

[43]  V. Falanga,et al.  Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. , 2007, Tissue engineering.

[44]  S. Akira,et al.  SnapShot: Pattern-Recognition Receptors , 2007, Cell.

[45]  D. Herndon,et al.  Propranolol does not increase inflammation, sepsis, or infectious episodes in severely burned children. , 2007, The Journal of trauma.

[46]  Y. Helfrich,et al.  Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. , 2007, The Journal of clinical investigation.

[47]  W. Maixner,et al.  β2 adrenergic receptor activation stimulates pro-inflammatory cytokine production in macrophages via PKA- and NF-κB-independent mechanisms , 2007 .

[48]  M. Kapsenberg,et al.  Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9. , 2007, The Journal of investigative dermatology.

[49]  Patrick M Flood,et al.  Beta2 adrenergic receptor activation stimulates pro-inflammatory cytokine production in macrophages via PKA- and NF-kappaB-independent mechanisms. , 2007, Cellular signalling.

[50]  T. Billiar,et al.  EMERGING PARADIGM: TOLL-LIKE RECEPTOR 4-SENTINEL FOR THE DETECTION OF TISSUE DAMAGE , 2006, Shock.

[51]  F. Cunha,et al.  Impaired neutrophil chemotaxis in sepsis associates with GRK expression and inhibition of actin assembly and tyrosine phosphorylation. , 2006, Blood.

[52]  K. Krogfelt,et al.  Multiple bacterial species reside in chronic wounds: a longitudinal study , 2006, International wound journal.

[53]  R. Isseroff,et al.  beta-Adrenergic receptor antagonists accelerate skin wound healing: evidence for a catecholamine synthesis network in the epidermis. , 2006, The Journal of biological chemistry.

[54]  R. Isseroff,et al.  β2‐Adrenergic receptor activation delays wound healing , 2006 .

[55]  S. Sozzani Dendritic cell migration , 2006 .

[56]  R. Isseroff,et al.  Beta2-adrenergic receptor activation delays wound healing. , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[57]  J. Campisi,et al.  Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines , 2005, Neuroscience.

[58]  Vincent Falanga,et al.  Wound healing and its impairment in the diabetic foot , 2005, The Lancet.

[59]  W. Yeh,et al.  IMPLICATION OF TOLL-LIKE RECEPTOR AND TUMOR NECROSIS FACTOR α SIGNALING IN SEPTIC SHOCK , 2005 .

[60]  P. Lindenauer,et al.  Perioperative beta-blocker therapy and mortality after major noncardiac surgery. , 2005, The New England journal of medicine.

[61]  R. Isseroff,et al.  ß2‐adrenergic receptor activation delays dermal fibroblast‐mediated contraction of collagen gels via a cAMP‐dependent mechanism , 2005, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[62]  W. Yeh,et al.  Implication of Toll-like receptor and tumor necrosis factor alpha signaling in septic shock. , 2005, Shock.

[63]  R. Ulevitch,et al.  Innate immune responses during infection. , 2004, Vaccine.

[64]  S. Leis,et al.  Catecholamine release in human skin—a microdialysis study , 2004, Experimental Neurology.

[65]  Shizuo Akira,et al.  Toll-like receptor signalling , 2004, Nature Reviews Immunology.

[66]  R. Kirsner,et al.  Microbiologic evaluation of skin wounds: alarming trend toward antibiotic resistance in an inpatient dermatology service during a 10-year period. , 2004, Journal of the American Academy of Dermatology.

[67]  A. Boulton,et al.  Protocol for treatment of diabetic foot ulcers. , 2004, American journal of surgery.

[68]  A. Albino-Teixeira,et al.  Homogeneous or heterogeneous distribution of systemically administered adrenaline: organ dependence , 1996, Naunyn-Schmiedeberg's Archives of Pharmacology.

[69]  H. Wagner,et al.  Differential Contribution of Toll-Like Receptors 4 and 2 to the Cytokine Response to Salmonella enterica Serovar Typhimurium and Staphylococcus aureus in Mice , 2003, Infection and Immunity.

[70]  Kaori Inoue,et al.  Beta2-adrenergic receptor antagonist accelerates skin barrier recovery and reduces epidermal hyperplasia induced by barrier disruption. , 2003, The Journal of investigative dermatology.

[71]  R. Isseroff,et al.  Beta-adrenergic receptor activation inhibits keratinocyte migration via a cyclic adenosine monophosphate-independent mechanism. , 2002, The Journal of investigative dermatology.

[72]  N. Ohata,et al.  Mycoplasmal Lipoproteins Induce Toll‐Like Receptor 2‐ and Caspases‐Mediated Cell Death in Lymphocytes and Monocytes , 2002, Microbiology and immunology.

[73]  L. Goldman,et al.  beta-Blockers and reduction of cardiac events in noncardiac surgery: scientific review. , 2002, JAMA.

[74]  Robert J. Lefkowitz,et al.  Seven-transmembrane-spanning receptors and heart function , 2002, Nature.

[75]  T. Tani,et al.  Lipopolysaccharide: neutralization by polymyxin B shuts down the signaling pathway of nuclear factor kappaB in peripheral blood mononuclear cells, even during activation. , 2001, The Journal of surgical research.

[76]  G. Maestroni Dendritic Cell Migration Controlled by α1b-Adrenergic Receptors1 , 2000, The Journal of Immunology.

[77]  C. Galanos,et al.  MALP-2, a Mycoplasma lipopeptide with classical endotoxic properties: end of an era of LPS monopoly? , 2000, Journal of endotoxin research.

[78]  S. Akira,et al.  Cutting Edge: TLR2-Deficient and MyD88-Deficient Mice Are Highly Susceptible to Staphylococcus aureus Infection1 , 2000, The Journal of Immunology.

[79]  J. Pugin,et al.  β-Adrenergic agonists exert their “anti-inflammatory” effects in monocytic cells through the IκB/NF-κB pathway , 2000 .

[80]  G. Maestroni Dendritic cell migration controlled by alpha 1b-adrenergic receptors. , 2000, Journal of immunology.

[81]  J. Pugin,et al.  beta-adrenergic agonists exert their "anti-inflammatory" effects in monocytic cells through the IkappaB/NF-kappaB pathway. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[82]  D Annane,et al.  Inappropriate sympathetic activation at onset of septic shock: a spectral analysis approach. , 1999, American journal of respiratory and critical care medicine.

[83]  Malcolm W Johnson The β -Adrenoceptor , 1998 .

[84]  R. Kirsner,et al.  Microbiologic evaluation of cutaneous wounds in hospitalized dermatology patients. , 1998, Ostomy/wound management.

[85]  G. Jung,et al.  Isolation, Structure Elucidation, and Synthesis of a Macrophage Stimulatory Lipopeptide from Mycoplasma fermentans Acting at Picomolar Concentration , 1997, The Journal of experimental medicine.

[86]  A. Wallace,et al.  Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. , 1996, The New England journal of medicine.

[87]  G. Born,et al.  Increase by adrenaline or angiotensin II of the accumulation of low density lipoprotein and fibrinogen by aortic walls in unrestrained conscious rats , 1996, British journal of pharmacology.

[88]  E. Moore,et al.  Evolving concepts in the pathogenesis of postinjury multiple organ failure. , 1995, The Surgical clinics of North America.

[89]  J. Bergquist,et al.  Discovery of endogenous catecholamines in lymphocytes and evidence for catecholamine regulation of lymphocyte function via an autocrine loop. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[90]  J. Last,et al.  Nicotine- or epinephrine-induced uteroplacental vasoconstriction and fetal growth in the rat. , 1994, Toxicology.

[91]  P. Howe,et al.  Lack of influence of circulating adrenaline on blood pressure in normotensive and hypertensive rats. , 1994, Blood pressure.

[92]  M. Bristow,et al.  Protective effect of clentiazem against epinephrine-induced cardiac injury in rats. , 1993, The Journal of pharmacology and experimental therapeutics.

[93]  D. Feliciano,et al.  The catecholamine response to multisystem trauma. , 1992, Archives of surgery.

[94]  D. Eikenburg,et al.  Chronic epinephrine treatment fails to alter prejunctional adrenoceptor modulation of sympathetic neurotransmission in the rat mesentery. , 1992, The Journal of pharmacology and experimental therapeutics.

[95]  Y. Yamori,et al.  Adrenaline in cardiovascular diseases--effect of beta-adrenoceptor antagonists. , 1990, Zeitschrift fur Kardiologie.

[96]  T. Riles,et al.  Beta blockade to decrease silent myocardial ischemia during peripheral vascular surgery. , 1990, American journal of surgery.

[97]  S. Trend,et al.  Resistance of the rat embryo to elevated maternal epinephrine concentrations. , 1989, American journal of obstetrics and gynecology.

[98]  J. Reid,et al.  The Effects of Chronic Administration of Adrenaline on the Function and Number of Adrenoceptors in the Rabbit , 1988, Journal of cardiovascular pharmacology.

[99]  D. Schwartz,et al.  Enhanced endogenous neurotransmitter overflow in the isolated perfused rat kidney after chronic epinephrine administration: lack of a prejunctional beta adrenoceptor influence. , 1988, The Journal of pharmacology and experimental therapeutics.

[100]  W. Terres,et al.  Blood platelet function after chronic treatment of rats and guinea pigs with nicotine. , 1988, Klinische Wochenschrift.

[101]  R. Isseroff,et al.  Conversion of linoleic acid into arachidonic acid by cultured murine and human keratinocytes. , 1987, Journal of lipid research.

[102]  D. Schwartz,et al.  Cardiovascular responsiveness to sympathetic activation after chronic epinephrine administration. , 1986, The Journal of pharmacology and experimental therapeutics.

[103]  Brian K. Kobilka,et al.  Cloning of the gene and cDNA for mammalian β-adrenergic receptor and homology with rhodopsin , 1986, Nature.

[104]  W. B. Jeffries,et al.  Withdrawal syndrome follows abrupt cessation of intracerebroventricular infusion of epinephrine in spontaneously hypertensive rats. , 1985, Life sciences.

[105]  H. B. Stoner,et al.  Plasma catecholamine concentrations in acute states of stress and trauma. , 1985, Archives of emergency medicine.

[106]  P. Khairallah,et al.  Adenylate Cyclase Activity in Rat Myocardium Following Chronic Infusions of Angiotensin II and Epinephrine , 1984, Journal of cardiovascular pharmacology.

[107]  H. Green,et al.  Seria cultivation of strains of human epidemal keratinocytes: the formation keratinizin colonies from single cell is , 1975, Cell.

[108]  H Green,et al.  Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. , 1975, Cell.